Multiple Sclerosis: Neuroprotection

Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system which is characterized by inflammatory demyelination and neurodegeneration. Here is the latest research on neuroprotective mechanisms in MS.

September 16, 2021
Review

The clinical use of curcumin on neurological disorders: An updated systematic review of clinical trials.

Phytotherapy Research : PTR
Maryam MohseniMohammad Bagherniya
September 10, 2021
Open Access

Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE.

International Journal of Molecular Sciences
Ranjithkumar RajendranMartin Berghoff
September 8, 2021
Review

CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases.

Pharmacology & Therapeutics
Meena S SubbarayanKevin R Nash
September 9, 2021

Functional role of ascorbic acid in the central nervous system: a focus on neurogenic and synaptogenic processes.

Nutritional Neuroscience
Morgana Moretti, Ana Lúcia S Rodrigues
September 7, 2021
Review
Open Access

The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations.

Frontiers in Immunology
Maedeh RadandishNafiseh Esmaeil
August 27, 2021
Review
Open Access

Reviewing the Significance of Blood-Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment.

International Journal of Molecular Sciences
Rodica BalasaDoina Manu
August 24, 2021

Diosgenin ameliorates cellular and molecular changes in multiple sclerosis in C57BL/6 mice.

Multiple Sclerosis and Related Disorders
Hossein ZeinaliMehrdad Roghani
August 23, 2021
Review

Memorable Food: Fighting Age-Related Neurodegeneration by Precision Nutrition.

Frontiers in Nutrition
Maja MiloševićVesna Vučić
August 20, 2021

Remyelination: what are the prospects for regenerative therapies in multiple sclerosis?

Emerging Topics in Life Sciences
Jonathan D Moore
August 20, 2021

Extracellular vesicles, stem cells and the role of miRNAs in neurodegeneration.

Current Neuropharmacology
Ayaz M BelkozhayevCornelia M Wilson
August 16, 2021

Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis.

Brain, Behavior, and Immunity
Francesca Romana RizzoAntonietta Gentile
August 11, 2021
Open Access

SRSF1-dependent inhibition of C9ORF72-repeat RNA nuclear export: genome-wide mechanisms for neuroprotection in amyotrophic lateral sclerosis.

Molecular Neurodegeneration
Lydia M CastelliGuillaume M Hautbergue
August 10, 2021
Preprint
Open Access

Fingolimod Regulates BDNF-AS and HOTAIR Expression in Multiple Sclerosis Patients

BioRxiv : the Preprint Server for Biology
F. khani HabibabadiMehrdad Behmanesh
August 10, 2021
Review
Open Access

PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases.

Pharmaceutics
Anthony CunhaBenjamin Dehay
August 7, 2021
Review
Open Access

The Therapeutic Potential of Celastrol in Central Nervous System Disorders: Highlights from In Vitro and In Vivo Approaches.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Stefania SchiavoneLuigia Trabace
August 7, 2021
Review
Open Access

Neuroprotective Potential of Limonene and Limonene Containing Natural Products.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Lujain Bader EddinShreesh Ojha

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

© 2021 Meta ULC. All rights reserved
/feed-previews/neuroprotection-in-ms/86523020-c073-4107-9feb-9dd433c8d94e